NSW Health pays the cost of the Pharmaceutical Benefit Scheme (PBS) co-payments for s100 Highly Specialised Drugs (HSD) and s100 injectable and infusible chemotherapy medicines for eligible NSW patients. This aims to lower the cost of medicines for people with some cancers and other chronic conditions.
In community pharmacy, the NSW Section 100 Co-payment Program applies to medicines listed on s100 HSD Community Access schedule (excluding opioid dependence medicines).
The s100 co-payment program also applies in public hospitals for
The Program does not apply to s100 medicines prescribed by private hospital providers or s100 medicines for opioid dependence treatment.
NSW Health pays the co-payment for s100 medicines for patients who meet the eligibility criteria and provide a completed consent form.
NSW residents who are patients of:
Prescribed medicines listed under section 100 of the National Health Act 1953 for:
Prescriptions filled through NSW:
The Patient Consent Form confirms the patient is eligible and has given consent to have their co-payment paid by NSW Health.
Eligible patients need to show the pharmacist their consent form each time a prescription/s and any repeats are dispensed. The form remains valid and can be accepted by pharmacists until the renewal period has expired. The patient is responsible for their form and may present a digital copy to the pharmacist.
Download patient consent form.
Community pharmacists are reimbursed for the cost of the co-payment and paid a service fee for submitting the claim by NSW Health.
Community pharmacies submit co-payment claims for eligible patients to the Pharmacy Guild of Australia (PGA) to be reimbursed. You do not need to be a PGA member to participate.
You can claim co-payments for medicines listed on the PBS - s100 Highly Specialised Drugs (HSD) Program (Community Access schedules) for:
PBS medicines prescribed under the s100 HSD – Private schedule or other s100 schedules cannot be claimed through this program. Medicines listed on s100 Community Access for opioid dependence treatment are not eligible.
Information and resources, including guides and frequently asked questions can be found on the PGA website
Please share information with your patients about the Program, by:
For further information scan the QR code below.